User:Mr. Ibrahem/Sotalol

Sotalol, sold under the brand name Betapace among others, is a medication used to treat and prevent abnormal heart rhythms. It is only recommended in those with significant abnormal heart rhythms due to potentially serious side effects. Evidence does not support a decreased risk of death with long term use. It is taken by mouth or injection into a vein.

Common side effects include a slow heart rate, chest pain, low blood pressure, feeling tired, dizziness, shortness of breath, problems seeing, vomiting, and swelling. Other serious side effects may include QT prolongation, heart failure, or bronchospasm. Sotalol is a non-selective beta-adrenergic receptor blocker which has both class II and class III antiarrhythmic properties.

Sotalol was first described in 1964 and came into medical use in 1974. It is available as a generic medication. A month supply in the United Kingdom costs the NHS about 5 £ as of 2019. In the United States the wholesale cost of this amount is about US$11. In 2017, it was the 267th most commonly prescribed medication in the United States, with more than one million prescriptions.